Active Ingredient(s): Calcium + Magnesium + Potassium + Sodium Oxybates
FDA Approved: * July 21, 2020
Pharm Company: * JAZZ PHARMS INC
Category: Narcolepsy

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Recent Xywav Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Calcium + Magnesium + Potassium + Sodium Oxybates
  • Solution: 0.234gm/ml + 0.096gm/ml + 0.13gm/ml + 0.04gm/ml, 0.5mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Xywav: (1 result)

Sorted by National Drug Code
  • 68727-150 Xywav Oral Solution by Jazz Pharmaceuticals, Inc.

Drugs with one or more similar ingredients: (214 results)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 3 August 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA